GB1276089A - Pharmaceutical preparations - Google Patents
Pharmaceutical preparationsInfo
- Publication number
- GB1276089A GB1276089A GB4041268A GB4041268A GB1276089A GB 1276089 A GB1276089 A GB 1276089A GB 4041268 A GB4041268 A GB 4041268A GB 4041268 A GB4041268 A GB 4041268A GB 1276089 A GB1276089 A GB 1276089A
- Authority
- GB
- United Kingdom
- Prior art keywords
- cores
- water
- particles
- outer layer
- pharmaceutically active
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
1276089 Pharmaceutical preparations. PFIZER Ltd 22 Aug 1969 [23 Aug 1968] 40412/ 68 Heading A5B Oral dosage units containing one or more pharmaceutically active ingredients comprising cores having an outer layer thereon consisting of particles of pharmaceutically active material or other material of pharmaceutical utility in a water-soluble matrix are prepared by forming the outer layer by spraying the cores with a suspension of the particles in a liquid medium comprising a water-soluble binding agent and a water-soluble cellulosic film-forming agent dissolved in a mixture of water and a watermiscible pharmaceutically acceptable organic liquid having a boiling point below 90‹C., and evaporating the solvent from the sprayed cores. The organic liquid may be acetone, ethanol or isopropanol; the binding agent may be sucrose, gelatine or gum acacia and the cellulosic film-forming agent may be hydroxypropyl methyl, methyl or sodium carboxymethyl cellulose. The particles deposited may form at least 10% by weight of the dosage unit. The cores may be sprayed with a suspension of a pharmaceutically active ingredient such as paracetamol, the core containing aspirin. The particles of material of pharmaceutical utility may comprise a pigment such as titanium dioxide. The core may be separated from the outer layer by an enteric layer of cellulose acetate phthalate.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB4041268A GB1276089A (en) | 1968-08-23 | 1968-08-23 | Pharmaceutical preparations |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB4041268A GB1276089A (en) | 1968-08-23 | 1968-08-23 | Pharmaceutical preparations |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1276089A true GB1276089A (en) | 1972-06-01 |
Family
ID=10414777
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB4041268A Expired GB1276089A (en) | 1968-08-23 | 1968-08-23 | Pharmaceutical preparations |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB1276089A (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0013263A2 (en) * | 1978-12-05 | 1980-07-09 | Aktiebolaget Hässle | A pharmaceutical preparation comprising a cardiac glycoside in combination with a polymer, and a process for preparation thereof |
EP0103991A2 (en) * | 1982-08-20 | 1984-03-28 | Bristol-Myers Squibb Company | Analgesic capsule |
EP0105065A1 (en) * | 1982-10-05 | 1984-04-11 | Kishan Narain Mathur | A pharmaceutical composition for pain relief |
US4673527A (en) * | 1985-05-20 | 1987-06-16 | Autotrol Corporation | Tablet granulation |
DK152831B (en) * | 1976-09-17 | 1988-05-24 | Richter Gedeon Vegyeszet | PROCEDURE FOR THE MANUFACTURING OF BIOLOGICALLY ACTIVE PREPARATIONS WITH REGULATED DELIVERY OF ACTIVE SUBSTANCE AND POLYMER-BASED LIQUID COATING PREPARATIONS FOR USING THE PROCEDURE |
EP0384514A2 (en) * | 1989-02-21 | 1990-08-29 | Norwich Eaton Pharmaceuticals, Inc. | Dual-action tablet |
GB2241168A (en) * | 1990-02-26 | 1991-08-28 | Int Medical Research Limited | Controlled release product containing salicylate |
WO2008129270A2 (en) * | 2007-04-18 | 2008-10-30 | Renaissance Pharma Ltd | Compositions comprising anti-inflammatory compounds |
-
1968
- 1968-08-23 GB GB4041268A patent/GB1276089A/en not_active Expired
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK152831B (en) * | 1976-09-17 | 1988-05-24 | Richter Gedeon Vegyeszet | PROCEDURE FOR THE MANUFACTURING OF BIOLOGICALLY ACTIVE PREPARATIONS WITH REGULATED DELIVERY OF ACTIVE SUBSTANCE AND POLYMER-BASED LIQUID COATING PREPARATIONS FOR USING THE PROCEDURE |
EP0013263A3 (en) * | 1978-12-05 | 1981-05-27 | Aktiebolaget Hassle | A pharmaceutical preparation comprising a cardiac glycoside in combination with a polymer, and a process for preparation thereof |
EP0013263A2 (en) * | 1978-12-05 | 1980-07-09 | Aktiebolaget Hässle | A pharmaceutical preparation comprising a cardiac glycoside in combination with a polymer, and a process for preparation thereof |
EP0103991A2 (en) * | 1982-08-20 | 1984-03-28 | Bristol-Myers Squibb Company | Analgesic capsule |
EP0103991A3 (en) * | 1982-08-20 | 1985-05-22 | Bristol-Myers Squibb Company | Analgesic capsule |
EP0105065A1 (en) * | 1982-10-05 | 1984-04-11 | Kishan Narain Mathur | A pharmaceutical composition for pain relief |
US4673527A (en) * | 1985-05-20 | 1987-06-16 | Autotrol Corporation | Tablet granulation |
EP0384514A2 (en) * | 1989-02-21 | 1990-08-29 | Norwich Eaton Pharmaceuticals, Inc. | Dual-action tablet |
EP0384514A3 (en) * | 1989-02-21 | 1991-04-03 | Norwich Eaton Pharmaceuticals, Inc. | Dual-action tablet |
GB2241168A (en) * | 1990-02-26 | 1991-08-28 | Int Medical Research Limited | Controlled release product containing salicylate |
US5156849A (en) * | 1990-02-26 | 1992-10-20 | Byrne Rynne Holdings Limited | Pharmaceutical composition |
WO2008129270A2 (en) * | 2007-04-18 | 2008-10-30 | Renaissance Pharma Ltd | Compositions comprising anti-inflammatory compounds |
WO2008129270A3 (en) * | 2007-04-18 | 2008-12-18 | Renaissance Pharma Ltd | Compositions comprising anti-inflammatory compounds |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI97445B (en) | A process for preparing a slow release pharmaceutical composition | |
US2991226A (en) | Long-acting wax-like talc pillage of penicillin | |
DE3855852T2 (en) | Spherical granules with a core and their manufacture | |
DE2336218C3 (en) | Oral dosage form | |
GB1161439A (en) | Pharmaceutical Compositions | |
GB1465781A (en) | Pharmaceutical preparations | |
CA2072933A1 (en) | Mechanically-stable, readily-disintegratable tablets made of small preformed particles containing active ingredients | |
CA2046739A1 (en) | Coated solid medicament form having releasability in large intestine | |
DE69816951D1 (en) | Preparation containing cefaclor or cephalexin with a modified release matrix | |
GB1276089A (en) | Pharmaceutical preparations | |
IL43022A (en) | An oral pharmaceutical composition containing cholestyramine coacervate | |
GB1385285A (en) | Pharmaceutical capsule wall materials | |
US3383283A (en) | Medicinal pellets coated with overlapping porous fatty acid leaflet layers | |
KR102149020B1 (en) | Film-coated tablet having high damp proof property | |
GB1202148A (en) | Pharmaceutical compositions | |
US2906665A (en) | L-amphetamine alginate | |
ES247237A1 (en) | Coated pharmaceutical granules and tablets thereof | |
GB793808A (en) | Sustained action pill | |
GB1302266A (en) | ||
HU183053B (en) | Process for heatstabilizing and form-stabilizing soft gelatine capsules containing active agents inside the envelope utilizable perlingual and buccal application | |
IE38614B1 (en) | Orally administrable corticosteroid preparations | |
AU446727B2 (en) | New derivatives of 4-chloro-5-sulfamoyl-anthranilic acid, their preparation and pharmaceutical compositions comprising them | |
DE2351860A1 (en) | MEDICINAL PRODUCTS CONTAINING SULFOGLYCOPEPTIDES WITH NATURAL OR SYNTHETIC NITROGENIC ORGANIC COMPOUNDS | |
IE35226B1 (en) | Pharmaceutical preparations | |
GB1375806A (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
PE20 | Patent expired after termination of 20 years |